In tumor protein p53 gene (TP53) mutant squamous cell carcinomas, metformin exploits metabolic dependencies created by higher glycolytic activity due to increased expression of glucose transporter 1 and hexokinase 2, for its anti-cancer mechanism [62]. The gene discussed is TP53; the disease is cancer.